Esperion Therapeutics ESPR Unrecognized Tax Benefits - Income Tax Penalties and Interest Accrued
Unrecognized Tax Benefits - Income Tax Penalties and Interest Accrued at other companies
Other financials
Where this comes from
Reported directly by Esperion Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued.
The official record: Esperion Therapeutics’s 10-K, filed March 10, 2026, on SEC EDGAR. View the filing →
Ask your AI about Esperion Therapeutics's unrecognized tax benefits - income tax penalties and interest accrued.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Esperion Therapeutics's unrecognized tax benefits - income tax penalties and interest accrued?
- Esperion Therapeutics (ESPR) reported unrecognized tax benefits - income tax penalties and interest accrued of $100K in Q4 2025.
- What does unrecognized tax benefits - income tax penalties and interest accrued mean?
- This metric tracks the accrued interest and penalties associated with the company's unrecognized tax benefits. It represents the additional cost the company would incur if its uncertain tax positions were disallowed by tax authorities. It serves as a proxy for the financial risk associated with the company's tax strategy.